Subramanian Sankar, Senior VP, Product Development at Nautilus Biotechnology, Inc. (NAUT), bought 75,000 shares at $2.16 ($163K) on 2022-09-16, disclosed to the SEC on 2022-09-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.19 | 40,000 | $88K | 53.7% |
| 2 | $2.16 | 35,000 | $76K | 46.3% |
| Total | $2.18 avg | 75,000 | $163K | 100% |